Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 03.02. ANTIBACTERIANOS | No observations |
| List | Section | Observation |
|---|---|---|
| El Salvador - 2019 | ANTIMICOBACTERIANOS | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.2.5. Antituberculosis medicines |
Others observations: Reserve second-line drugs for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control. |
| PAHO Strategic Fund Medicine List | 2.4. Antiberculosis med. 2nd line | No observations |
| Haiti. National List of Essential Medicines | 06.02.04 Anti-tuberculosis drugs | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.2.5. Antituberculosis medicines |
Others observations: Reserve second-line drugs for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control. |
| PAHO Strategic Fund Medicine List | 2.4. Antiberculosis med. 2nd line | No observations |
| Peru | 6.2.4 Anti-Tuberculosis | No observations |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 03. Antituberculosos | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | J. ANTI-INFECCIOSOS PARA USO SISTEMICO | No observations |
| El Salvador - 2019 | ANTIMICOBACTERIANOS | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 06.03. ANTITUBERCULOSOS | No observations |
| Guyana. Essential Medicines List. 2020-2021 | Reserve Second-line medicines used to treat (MDR-TB) | No observations |
| Haiti. National List of Essential Medicines | 06.02.04 Anti-tuberculosis drugs | No observations |
| List | Section | Observation |
|---|---|---|
| Ecuador | Essential Medicines List - Ecuador | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.2.5. Antituberculosis medicines |
This medicine requires a children care specialist. |
| List | Section | Observation |
|---|---|---|
| PAHO Strategic Fund Medicine List | 2.4. Antiberculosis med. 2nd line | No observations |